Biovitrum's CEO Martin Nicklasson will give a company presentation at
the 27th Annual J.P. Morgan Healthcare Conference being held January
12-15, 2009, in San Francisco, USA.
The presentation is scheduled to take place on Wednesday January 14
at 4:00 p.m. (PST). A live webcast, as well as an archived, will be
available via Biovitrums website at www.biovitrum.com.
The presentation material will be available on www.biovitrum.com
under the link presentations on the investor relations page.
For more information please contact:
Biovitrum
Göran Arvidson, CFO
Phone: +46 8 697 23 68
About Biovitrum
Biovitrum is a pharmaceutical company with operations in Sweden and
in the UK. The company markets a range of specialist pharmaceuticals.
Using its expertise and experience Biovitrum takes scientific
innovation all the way to the market and to specialist indication
patients with significant medical need. Research expertise and
capabilities include development and production of biotechnology
therapeutics, as well as small molecule discovery and development.
With revenues of approximately SEK 1.3 billion and around 500
employees, Biovitrum is a significant international specialty
pharmaceutical player. Biovitrum's share is listed on the OMX Nordic
Exchange in Stockholm. For more information go to www.biovitrum.com
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.
http://hugin.info/134557/R/1281605/286620.pdf
Copyright © Hugin AS 2009. All rights reserved.